Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378


Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.

Hu CC, Jeng WJ, Chen YC, Fang JH, Huang CH, Teng W, Hsieh YC, Lin YC, Chien RN, Sheen IS, Lin CY.

Sci Rep. 2017 Nov 10;7(1):15280. doi: 10.1038/s41598-017-15527-x.


CTLA-4 Gene Haplotypes and the Risk of Chronic Hepatitis C Infection; a Case Control Study.

Sepahi S, Pasdar A, Gerayli S, Rostami S, Gholoobi A, Meshkat Z.

Rep Biochem Mol Biol. 2017 Oct;6(1):51-58.


Interaction and Mutual Activation of Different Innate Immune Cells Is Necessary to Kill and Clear Hepatitis C Virus-Infected Cells.

Klöss V, Grünvogel O, Wabnitz G, Eigenbrod T, Ehrhardt S, Lasitschka F, Lohmann V, Dalpke AH.

Front Immunol. 2017 Sep 29;8:1238. doi: 10.3389/fimmu.2017.01238. eCollection 2017.


Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation.

Zhan W, Kang Y, Chen N, Mao C, Kang Y, Shang J.

Drug Des Devel Ther. 2017 Oct 10;11:2947-2955. doi: 10.2147/DDDT.S149623. eCollection 2017.


Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B.

Ge J, Huang Z, Liu H, Chen J, Xie Z, Chen Z, Peng J, Sun J, Hou J, Zhang X.

Front Immunol. 2017 Sep 22;8:1173. doi: 10.3389/fimmu.2017.01173. eCollection 2017.


Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy.

Xu Y, Liu Y, Zhao M, Chen Y, Xie C, Gong M, Deng H, Li X, Sun J, Hou J, Wu H, Wang Z.

Front Immunol. 2017 Sep 14;8:1142. doi: 10.3389/fimmu.2017.01142. eCollection 2017.


Age- and Sex-associated Differences in Phenotypic and Functional Characteristics of Peripheral Blood Lymphocytes in Chimpanzees (Pan troglodytes).

Nehete PN, Magden ER, Nehete BP, Williams LE, Abee CR, Sastry KJ.

J Am Assoc Lab Anim Sci. 2017 Sep 1;56(5):509-519.


Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.

Hösel M, Quasdorff M, Ringelhan M, Kashkar H, Debey-Pascher S, Sprinzl MF, Bockmann JH, Arzberger S, Webb D, von Olshausen G, Weber A, Schultze JL, Büning H, Heikenwalder M, Protzer U.

Cell Mol Gastroenterol Hepatol. 2017 Jul 19;4(3):339-363. doi: 10.1016/j.jcmgh.2017.07.003. eCollection 2017 Nov.


Sero-prevalence of hepatitis B infection among blood donors in a secondary care hospital, Ghana (2014): a retrospective analysis.

Osei E, Lokpo SY, Agboli E.

BMC Res Notes. 2017 Aug 10;10(1):391. doi: 10.1186/s13104-017-2733-3.


Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.

Ghouri YA, Mian I, Rowe JH.

J Carcinog. 2017 May 29;16:1. doi: 10.4103/jcar.JCar_9_16. eCollection 2017. Review.


Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines.

Torres-Cornejo A, Lauer GM.

Pathog Immun. 2017;2(1):102-125. doi: 10.20411/pai.v2i1.201. Epub 2017 Apr 9.


A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection.

Yi P, Liang Y, Yuan DMK, Jie Z, Kwota Z, Chen Y, Cong Y, Fan X, Sun J.

Sci Rep. 2017 Jun 20;7(1):3857. doi: 10.1038/s41598-017-04260-0.


Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis.

Pereira LMS, Gomes STM, Ishak R, Vallinoto ACR.

Front Immunol. 2017 May 26;8:605. doi: 10.3389/fimmu.2017.00605. eCollection 2017. Review.


Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.

Ho CH, Tsai HW, Lee CY, Huang LJ, Chien RN, Wu IC, Chiu YC, Liu WC, Cheng PN, Chang TT, Chen SH.

Sci Rep. 2017 May 16;7(1):1957. doi: 10.1038/s41598-017-02158-5.


Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.

Yu Y, Wan P, Cao Y, Zhang W, Chen J, Tan L, Wang Y, Sun Z, Zhang Q, Wan Y, Zhu Y, Liu F, Wu K, Liu Y, Wu J.

Sci Rep. 2017 May 11;7(1):1729. doi: 10.1038/s41598-017-01773-6.


Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies.

Sandhu P, Haque M, Humphries-Bickley T, Ravi S, Song J.

Front Immunol. 2017 Apr 13;8:436. doi: 10.3389/fimmu.2017.00436. eCollection 2017. Review.


Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B.

Fan YC, Zhang YY, Wang N, Sun YY, Wang K.

Oncotarget. 2017 May 9;8(19):30781-30792. doi: 10.18632/oncotarget.15683.

Supplemental Content

Support Center